Privia Health Group Inc
$ 24.91
9.98%
26 Feb - close price
- Market Cap 2,785,985,000 USD
- Current Price $ 24.91
- High / Low $ 25.16 / 23.04
- Stock P/E 161.79
- Book Value 5.77
- EPS 0.14
- Next Earning Report 2026-02-26
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.01 %
- ROE 0.03 %
- 52 Week High 26.51
- 52 Week Low 18.77
About
Privia Health Group, Inc. is a population health technology and medical practice management company in the United States.
Analyst Target Price
$31.25
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-06 | 2025-08-07 | 2025-05-07 | 2025-02-25 | 2024-11-07 | 2024-08-08 | 2024-05-09 | 2024-02-27 | 2023-11-03 | 2023-08-03 | 2023-05-04 | 2023-02-28 |
| Reported EPS | 0.29 | 0.02 | 0.22 | 0.21 | 0.03 | 0.03 | 0.02 | 0.02 | 0.05 | 0.06 | 0.06 | 0.14 |
| Estimated EPS | 0.05 | 0.05 | 0.1818 | 0.2008 | 0.05 | 0.05 | 0.05 | 0.04 | 0.05 | 0.06 | 0.02 | -0.03 |
| Surprise | 0.24 | -0.03 | 0.0382 | 0.0092 | -0.02 | -0.02 | -0.03 | -0.02 | 0 | 0 | 0.04 | 0.17 |
| Surprise Percentage | 480% | -60% | 21.0121% | 4.5817% | -40% | -40% | -60% | -50% | 0% | 0% | 200% | 566.6667% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-02-26 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | 0.04 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: PRVA
2026-02-26 14:53:21
Privia Health reported strong Q4 and full-year 2025 results, with an increase in implemented providers, attributed lives, and significant growth in adjusted EBITDA and free cash flow. The company highlighted its successful acquisition of Evolent Health's ACO business, robust cash position with no debt, and provided optimistic 2026 guidance. Management also discussed strategic priorities, including continued capital deployment for M&A, leveraging AI and technology for efficiency, and navigating the evolving Medicare Advantage contracting environment.
2026-02-26 13:53:21
Privia Health is set to release its Q1 2026 earnings, with analysts anticipating year-on-year revenue growth. The company previously surpassed revenue and earnings per share forecasts, maintaining consistent performance expectations. While the broader healthcare technology sector and Privia Health's stock have seen declines, the average analyst price target for Privia Health remains above its current trading price.
2026-02-26 11:53:21
Privia Health Group Inc. reported strong fourth-quarter earnings, with a profit of 7 cents per share and revenue of $541.2 million, both exceeding Wall Street expectations. For the full year, the company posted a profit of $22.9 million and revenue of $2.12 billion. Privia Health projects full-year revenue for the upcoming period to be between $2.35 billion and $2.45 billion.
2026-02-26 11:53:21
Privia Health Group Inc. reported strong financial results for the fourth quarter, with a net income of $9.2 million and earnings per share of 7 cents, exceeding analyst estimates. The company also surpassed revenue projections, generating $541.2 million for the quarter and $2.12 billion for the full year. Privia Health anticipates annual revenue between $2.35 billion and $2.45 billion in the upcoming period.
2026-02-26 11:53:21
Privia Health Group, Inc. (PRVA) reported strong Q4 2025 revenues of $541.2 million, significantly exceeding FactSet's estimated $516.2 million. The company's business model focuses on physician enablement through its technology-driven "Privia Platform," which supports comprehensive healthcare services for various provider types. Privia Health also announced Q4 adjusted EPS of $0.25 alongside its positive revenue report.
2026-02-26 10:53:21
Privia Health (PRVA) announced strong financial and operational results for the fourth quarter and full-year ending December 31, 2025, surpassing its guidance. The company reported significant increases in revenue, net income, and adjusted EBITDA, along with growth in implemented providers and attributed lives. Privia Health maintains a strong balance sheet with no debt and projects continued growth with a 20% increase in Adjusted EBITDA for 2026.
